Steadily Registered Glucose Raising Agent Market

Sub Levels

NEWARK, NEWCASTLE, USA, May 3, 2023 (GLOBE NEWSWIRE) — Growth Plus Reports glucose elevating agent Revenue is expected to increase in 2022 CAGR 6.3% During the forecast period 2023-2031.

The global market for glucose-raising agents has been analyzed and is expected to rise with a significant revenue share during the forecast period. Drugs that raise blood sugar levels are known as glucose-raising agents. In patients with low blood sugar, these drugs treat hypoglycemia, insulinoma, and other diabetes-related disorders.

Important points:

  • Increased adoption of glucose monitoring devices is also driving the demand for glucose raising agents.
  • Rapid advancement of innovative healthcare devices is driving the market demand.
  • Increasing prevalence of diabetes is increasing the revenue share of the market.

Get a free sample research report:

Market Scope of Glucose Raising Agents

report attribute detail
CAGR 6.3%
Estimation base year 2022
Forecast period 2023-2031
history year 2021
Target segment Product, Indication, Route of Administration, Distribution Route/Region
Area range North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Recent developments in the global hyperglycemic agents market:

  • From December 1, 2022, Novo Nordisk Pharma will sell “Glucagon G Novo 1mg” on behalf of EA Pharma Co., Ltd.

competitive environment

A list of prominent players operating in the global Glucose Raising Agents market includes:

  • E5 Pharma Co., Ltd.
  • Novitium Pharma
  • Eli Lilly and Company
  • Par Pharmaceutical
  • Teva Pharmaceuticals USA, Inc.

Market drivers and constraints:

Global glucose elevating agents market revenue is driven by diabetes prevalence, increasing adoption of glucose monitoring devices, and increasing reliability of cost-effective solutions. Moreover, growing interest in developing innovative and advanced devices to monitor glucose levels in seconds may contribute to the potential growth of global market revenue.

However, the severe regulatory environment is expected to restrain the market revenue share.

Market segmentation:

  • Based on product, the global glucose raiser market is segmented into glucagon, diazoxide, vitamins & supplements and others.
  • Based on indication, the global glucose-elevating agents market is segmented into hypoglycemia, diabetic ketoacidosis, adrenal insufficiency, insulinoma and others.
  • Based on route of administration, the global glucose-raising agents market is segmented into oral and parenteral.
  • Based on distribution channel, the global glucose-raising drugs market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

Customization Request –

Segmentation by indication

Based on indication, the hypoglycemic segment with the largest revenue share dominates the global glucose-raising agents market. This large revenue share is attributed to being the most common complication of diabetes treatment. In addition, more and more people are leading a sedentary lifestyle due to drinking alcohol and lack of exercise.

Regional growth dynamics

Based on region, the global glucose raiser market is segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. North America, with the largest revenue share, dominates the global market due to the large number of patient populations suffering from diabetes, significant market players, and high level of knowledge and awareness.

report coverage

Growth Plus Reports has provided an in-depth analysis of the global market for glucose-raising agents. Basic market characteristics, key investment sectors, regional growth analysis, revenue forecasts, competitive market players, mergers and acquisitions have been studied.

table of contents

  1. prologue
    1. market ecosystem
    2. timeline under consideration
      1. Historic year – 2021
      2. Base Year – 2022
      3. Forecast Year – 2023 to 2031
    3. Currency used in reports
  2. research method
    1. research approach
    2. Data collection method
    3. data source
      1. secondary source
      2. primary source
    4. Market estimation approach
      1. bottom up
      2. top down
    5. Market forecast model
    6. Limitations and Assumptions
  3. Premium Insight
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players and Competitive Positioning (2022)
    3. Regulatory status
  4. market dynamics
    1. driver
    2. restraint/challenge
    3. chance
  5. Global Glucose Raise Market – Analysis and Forecast, By Product
    1. glucagon
    2. diazoxide
    3. vitamins and supplements
    4. others
  6. Global Glucose Raising Drugs Market – Analysis and Forecast by Indication
    1. hypoglycemia
    2. diabetic ketoacidosis
    3. adrenal insufficiency
    4. insulinoma
    5. others
  7. Global Glucose Raising Agents Market- Analysis and Forecast by Administration Path
    1. Oral
    2. Parenteral

TOC of Glucose Raising Agents Market

Purchase this premium research report:

Value proposition related to the report:

  • Featuring free analyst time and expert interviews for each report
  • Comprehensive quantitative and qualitative insights at segment and subsegment level
  • Covid 19 impact trends and outlook
  • Detailed insights at global/regional/country level
  • Deep insight into market dynamics (drivers, constraints, opportunities) and business environment
  • Comprehensive coverage of the competitive environment
  • victory conditions
  • Exhaustive coverage on “strategic developments” registered by key players in the market

Customization options:

  • Distributor Landscape Assessment
  • price intelligence
  • Customer base evaluation
  • Analysis of investments and initiatives
  • “Business Profiles” of Key Players

Schedule a call with an analyst.

– Visit our report store.

See more of our latest healthcare reports:

Biological and chemical indicators market By Type (Biological and Chemical Indicators), End Users (Biopharmaceutical Industry, Academic and Research Institutes) – Global Outlook and Forecasts 2023-2031

Gene therapy in the central nervous system market By indication (Alzheimer’s disease, Huntington’s disease, Parkinson’s disease), type (ex vivo, in vivo), end-user (hospitals, specialty clinics) – global outlook and forecasts from 2023 to 2031

Secondary myelofibrosis drug market By Drug Class (Janus Kinase Inhibitors, Immunomodulators), Distribution Channels (Hospital Pharmacy, Retail Pharmacy) – Global Outlook and Forecast 2023-2031

Ergocalciferol Market By Application (Hypoparathyroidism, Rickets), Route of Administration (Oral, Injectable), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) – Global Outlook and Forecast 2023-2031

MISME Syndrome Market By Treatment (Surgery, Radiotherapy, Pharmacotherapy) – Global outlook and forecasts from 2023 to 2031

about us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge services company. We are proud to be members of the EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus’ portfolio of services leverages core capabilities such as secondary and primary research, market modeling and forecasting, benchmarking, analytics, and strategy development to create scalable, breakthrough solutions that prepare clients for future growth and success. We will help you to do so.

We have been honored as “Most Innovative Healthcare Market Research Firm in 2020” by the prestigious CEO Magazine.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *